Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL) (C-Term) Peptide

CBL Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5512802
  • Target See all CBL products
    CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
    Protein Region
    C-Term
    Origin
    Human
    Source
    • 5
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Sequence
    GEGNLAAAHA NTGPEESENE DDGYDVPKPP VPAVLARRTL SDISNASSSF
    Characteristics
    This is a synthetic peptide designed for use in combination with anti- CBL Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    CBL (Cas-Br-M (Murine) Ecotropic Retroviral Transforming Sequence (CBL))
    Synonyms
    4732447J05Rik Peptide, Cbl-2 Peptide, c-Cbl Peptide, cbl Peptide, C-CBL Peptide, CBL2 Peptide, FRA11B Peptide, NSLL Peptide, RNF55 Peptide, c-cbl-like Peptide, RGD1561386 Peptide, Casitas B-lineage lymphoma Peptide, Cbl proto-oncogene Peptide, Cbl Peptide, CBL Peptide
    Background
    This gene is a proto-oncogene that encodes a RING finger E3 ubiquitin ligase. The encoded protein is one of the enzymes required for targeting substrates for degradation by the proteasome. This protein mediates the transfer of ubiquitin from ubiquitin conjugating enzymes (E2) to specific substrates. This protein also contains an N-terminal phosphotyrosine binding domain that allows it to interact with numerous tyrosine-phosphorylated substrates and target them for proteasome degradation. As such it functions as a negative regulator of many signal transduction pathways. This gene has been found to be mutated or translocated in many cancers including acute myeloid leukaemia. Mutations in this gene are also the cause of Noonan syndrome-like disorder.

    Alias Symbols: CBL2, NSLL, C-CBL, RNF55, FRA11B

    Protein Size: 906
    Gene ID
    867
    NCBI Accession
    NM_005188, NP_005179
    UniProt
    P22681
You are here:
Support